title: Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate.
abstract: BACKGROUND
  Sevelamer hydrochloride is a recently approved calcium- and aluminium-free phosphate binder. A randomized study comparing sevelamer and calcium acetate was performed to assess the control of hyperphosphatemia in hemodialysis patients.
  
  
  METHODS
  Administration of phosphate binders was discontinued during a two-week washout period. The patients were then randomized to receive sevelamer or calcium acetate. The laboratory tests were performed monthly for 34 weeks.
  
  
  RESULTS
  There was a statistically significant decrease of serum phosphorus in both sevelamer and calcium acetate treatments. In addition, sevelamer improved the lipid profile.
  
  
  CONCLUSIONS
  This study confirms that sevelamer is effective at lowering serum phosphorus in hemodialysis patients and that it has several striking properties that could be beneficial in atherosclerosis in dialysis patients.
authors.affiliation: Nephrology Unit, San Cecilio Hospital, University of Granada, Spain. jhervas@ugr.es
authors.forename: José G
authors.initials: JG
authors.lastname: Hervás
authors.forename: Dolores
authors.initials: D
authors.lastname: Prados
authors.forename: Sebastián
authors.initials: S
authors.lastname: Cerezo
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D002118:Calcium / Q000097:blood; D017610:Calcium Compounds; D004852:Epoxy Compounds / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood*; D010758:Phosphorus / Q000097:blood; D011073:Polyamines; D011095:Polyethylenes / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000009:adverse effects*; D000069603:Sevelamer
chemical_list: D000085:Acetates; D017610:Calcium Compounds; D004852:Epoxy Compounds; D008055:Lipids; D010281:Parathyroid Hormone; D010710:Phosphates; D011073:Polyamines; D011095:Polyethylenes; D010758:Phosphorus; D000069603:Sevelamer; D000469:Alkaline Phosphatase; D002118:Calcium; C120662:calcium acetate